Avert-IT

Intensive Care patients can experience Adverse Events associated with sudden episodes of low blood pressure. These Adverse Events may impact all of the main organs resulting in longer lengths of stay, increased care costs and reducing quality of outcomes. Existing technologies enable to clinicians to know when these events have occurred and treat the effects.

Medical techniques for avoiding Adverse Events currently exist, but clinicians don#t have a reliable way to predict the occurrence, so there is no opportunity for intervention.

Research indicates average lengths of stay can be reduced by up to 30%, and outcomes improved for a similar proportion of patients, if these Adverse Events can be avoided through prediction and intervention. Potential savings across the EU exceed 5 billion euros, annually.

A model for predicting Adverse Events offers potential for improving outcomes across a wide range of conditions and or illnesses.

The main objectives of the project are:

  • Understanding the association between multiple patient parameters and arterial hypotension (sudden drop in blood pressure)
  • Development of a software application to predict the occurrence of arterial hypotension based on recognition of the associations described above
  • Validation of the solution in clinical trials
  • Exploitation model for the commercialisation of the software in product/service sales across international markets

For further information, please visit:
http://avertit.wordpress.com (Avert-IT Project Blog)

Project co-ordinator:
Pera Innovation Ltd.

Partners:

  • C3 Amulet Ltd
  • Uppsala Universitet
  • Universitätsklinikum Heidelberg
  • Azienda Ospedaleria San Gerardo Di Monza
  • Kauno Technologijos Universitetas
  • The University Of Glasgow
  • Greater Glasgow Health Board
  • Hospital Universitari Vall d'Hebron
  • Philips Medizin Systeme Böblingen Gmbh.

Timetable: from 01/2008 € to 12/2010

Total cost: € 2.286.138

EC funding: € 1.780.000

Programme Acronym: FP7-ICT

Subprogramme Area: Advanced ICT for risk assessment and patient safety

Contract type: Collaborative project (generic)


Related news article:

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...

Call for Papers: AI Applications in Biom…

JMIR Biomedical Engineering is inviting submissions for a new section titled "AI Applications in Biomedical Engineering." This themed section explores the integration of biomedical engineering and artificial intelligence (AI), focusing...